The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women

Sexually Transmitted Infections

Volumn 88, Issue 8, 2012, Pages 627-632

  Nielsen, Ann ^a   Iftner, Thomas ^b   Nørgaard, Mia ^a   Munk, Christian ^a   Junge, Jette ^c   Kjaer, Susanne Krüger ^a,c  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; FEMALE; GERMANY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CYTOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVIX UTERI; CROSS-SECTIONAL STUDIES; CYTOLOGICAL TECHNIQUES; DENMARK; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

EID: 84871608822     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050307     Document Type: Article

References (30)

1. Burchell AN, Winer RL, de Sanjose S, et al. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24(Suppl 3):S52-61. (Pubitemid 44293018)
2. Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003:14-19.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19. (Pubitemid 29406813)
4. Syrjänen KJ. Natural history of genital human papillomavirus infections. In: Lacey C, ed. Papillomavirus reviews: Current research on Papillomaviruses. Leeds: Leeds University Press, 1996.
5. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27. (Pubitemid 36159887)
6. Clifford GM, Gallus S, Herrero R, et al . Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8. (Pubitemid 41323035)
7. de Sanjosé S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7:453-9. (Pubitemid 46962343)
8. Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008;43:S5-25, S25.
9. Kjaer SK, Breugelmans G, Munk C, et al. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008;123:1864-70.
10. Danish National Board of Health. Cervical Cancer Screening - Recommendations. Copenhagen: Danish National Board of Health, 2007.
11. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101. (Pubitemid 44116919)
12. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57:68-72. (Pubitemid 38091314)
13. Goodman MT, Shvetsov YB, McDuffie K, et al . Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008;68:8813-24.
14. Trottier H, Mahmud S, Prado JC, et al. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 2008;197:1436-47. (Pubitemid 351706468)
15. Manhart LE, Holmes KK, Koutsky LA, et al . Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis 2006;33:502-8. (Pubitemid 44126894)
16. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-19. (Pubitemid 46333946)
17. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005;191:1796-807. (Pubitemid 40705385)
18. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183:1554-64. (Pubitemid 32466692)
19. Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002;185:28-35. (Pubitemid 34043013)
20. Sukvirach S, Smith JS, Tunsakul S, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187:1246-56. (Pubitemid 36438965)
21. Iftner T, Villa LL. Chapter 12: human papillomavirus technologies. J Natl Cancer Inst Monogr 2003:80-8.
22. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005;32(Suppl 1):S16-24. (Pubitemid 40332585)
23. Shin HR, Franceschi S, Vaccarella S, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004;190:468-76. (Pubitemid 38982082)
24. Thomas JO, Herrero R, Omigbodun AA, et al . Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638-45. (Pubitemid 38297204)
25. Stevens MP, Garland SM, Tan JH, et al. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol 2009;81:1283-91.
26. Zuna RE, Allen RA, Moore WE, et al. Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Mod Pathol 2007;20:167-74. (Pubitemid 46422170)
27. Pretet JL, Jacquard AC, Saunier M, et al. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol 2008;110:179-84.
28. Bello BD, Spinillo A, Alberizzi P, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 2009;81:703-12.
29. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2011;100B:261-319.
30. Danish National Board of Health. The Use of Liquid Based Cytology (LBC) and Conventional Pap Smear for Cervical Cancer Screening in DenmarkdA Health Technology assessment. Copenhagen: Danish National Board of Health, 2005.